1. Home
  2. ASMB vs FNKO Comparison

ASMB vs FNKO Comparison

Compare ASMB & FNKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • FNKO
  • Stock Information
  • Founded
  • ASMB 2005
  • FNKO 2017
  • Country
  • ASMB United States
  • FNKO United States
  • Employees
  • ASMB N/A
  • FNKO N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • FNKO Recreational Games/Products/Toys
  • Sector
  • ASMB Health Care
  • FNKO Consumer Discretionary
  • Exchange
  • ASMB Nasdaq
  • FNKO Nasdaq
  • Market Cap
  • ASMB 196.9M
  • FNKO 170.7M
  • IPO Year
  • ASMB 2010
  • FNKO 2017
  • Fundamental
  • Price
  • ASMB $27.47
  • FNKO $3.05
  • Analyst Decision
  • ASMB Strong Buy
  • FNKO Buy
  • Analyst Count
  • ASMB 4
  • FNKO 4
  • Target Price
  • ASMB $42.33
  • FNKO $7.13
  • AVG Volume (30 Days)
  • ASMB 156.9K
  • FNKO 1.2M
  • Earning Date
  • ASMB 11-06-2025
  • FNKO 11-06-2025
  • Dividend Yield
  • ASMB N/A
  • FNKO N/A
  • EPS Growth
  • ASMB N/A
  • FNKO N/A
  • EPS
  • ASMB N/A
  • FNKO N/A
  • Revenue
  • ASMB $33,247,000.00
  • FNKO $970,702,000.00
  • Revenue This Year
  • ASMB $14.32
  • FNKO N/A
  • Revenue Next Year
  • ASMB N/A
  • FNKO $10.57
  • P/E Ratio
  • ASMB N/A
  • FNKO N/A
  • Revenue Growth
  • ASMB 54.77
  • FNKO N/A
  • 52 Week Low
  • ASMB $7.75
  • FNKO $2.22
  • 52 Week High
  • ASMB $27.90
  • FNKO $14.65
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 65.33
  • FNKO 41.56
  • Support Level
  • ASMB $23.21
  • FNKO $2.90
  • Resistance Level
  • ASMB $27.17
  • FNKO $3.49
  • Average True Range (ATR)
  • ASMB 1.70
  • FNKO 0.20
  • MACD
  • ASMB 0.29
  • FNKO -0.06
  • Stochastic Oscillator
  • ASMB 97.82
  • FNKO 11.94

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About FNKO Funko Inc.

Funko Inc is an USA based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.

Share on Social Networks: